Colloid systems and wetting agents; subcombinations thereof; pro – Compositions containing a wetting agent; processes of... – The agent contains organic compound containing sulfoxy*
Reexamination Certificate
2005-09-13
2005-09-13
Desai, Rita (Department: 1625)
Colloid systems and wetting agents; subcombinations thereof; pro
Compositions containing a wetting agent; processes of...
The agent contains organic compound containing sulfoxy*
56, C544S361000
Reexamination Certificate
active
06943199
ABSTRACT:
Substituted spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines capable of modulating NPY5 receptor activity are provided. Such compounds may be used to modulate ligand binding to NPY5 receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of disorders (e.g., eating disorders such as obesity or bulimia, psychiatric disorders, diabetes and cardiovascular disorders such as hypertension) in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such compounds for detecting NPY5 receptors.
REFERENCES:
patent: 5602024 (1997-02-01), Gerald et al.
patent: 6372743 (2002-04-01), Darrow et al.
patent: 6506762 (2003-01-01), Horvath et al.
patent: 6566367 (2003-05-01), Bakthavatchalam et al.
patent: 6696445 (2004-02-01), Horvath et al.
patent: 2001/0031474 (2001-10-01), Kinrade et al.
patent: 2003/0069246 (2003-04-01), Darrow et al.
patent: 2003/0144290 (2003-07-01), Blum et al.
patent: 55-143980 (1980-11-01), None
patent: WO 95/28389 (1995-10-01), None
patent: WO 00/06545 (2000-02-01), None
patent: WO 00/27845 (2000-05-01), None
patent: 0027845 (2000-05-01), None
patent: 0114376 (2001-03-01), None
patent: WO 01/14376 (2001-03-01), None
patent: 0123387 (2001-04-01), None
patent: WO 01/23387 (2001-04-01), None
patent: WO 01/23389 (2001-04-01), None
patent: WO 01/55103 (2001-08-01), None
patent: 0195856 (2001-12-01), None
patent: WO 02/48152 (2002-06-01), None
patent: WO 03/104255 (2003-12-01), None
Communication pursuant to Article 96(2) EPC, for European Patent Application No. 01 270 536.4, dated Nov. 28, 2003.
Michel, Martin C., et al. “XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, . . . ”Pharmacological Reviews, vol. 50, No. 1 (1998) pp 143-150.
De Lombaert Stephane
Hutchison Alan
Zheng Xiaozhang
Desai Rita
Guterman Sonia K.
Lawson & Weitzen, LLP
Neurogen Corporation
LandOfFree
Spiro[isobenzofuran-1,4′-piperidin]-3-ones and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spiro[isobenzofuran-1,4′-piperidin]-3-ones and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro[isobenzofuran-1,4′-piperidin]-3-ones and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3403846